Konstantin Dobrenkov
Senior Clinical Director, Early Oncology Development @ Merck
About Konstantin Dobrenkov
Konstantin Dobrenkov serves as the Senior Clinical Director for Early Oncology Development at Merck, a position he has held since 2016. He previously worked as a Clinical Fellow at Memorial Sloan Kettering Cancer Center from 2012 to 2015 and earned his Doctor of Medicine degree from The Russian State Medical University.